Mina Tempaku
Tsu, 5148507, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
SREBP-driven lipogenesis coupled with ferroptosis resistance as a therapeutic target in PTEN-loss extrahepatic cholangiocarcinoma.
Journal: JHEP reports : innovation in hepatology
Published: March 03, 2026
The Conjugated Bile Acids Profile Suggests a Novel Liver-Muscle Axis Associated With Sarcopenia in Chronic Liver Disease.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 17, 2025
Elevation of Immunoglobulin Free Light Chain and BAFF Levels Associated With Immune Activation Predicts Survival Rates in Chronic Liver Disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 15, 2025
Plexin Domain Containing 2, a Protein Specifically Expressed and Elevated in Human Pancreatic Cancer Tissue and Serum, Influences Cell Proliferation by Correlating With Cortactin.
Journal: Cancer medicine
Published: January 16, 2025
AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.
Journal: Hepatology (Baltimore, Md.)
Published: November 26, 2024
Serum Zinc-α2-glycoprotein Levels Are Associated with the Hepatorenal Function and Predict the Survival in Cases of Chronic Liver Disease.
Journal: Internal medicine (Tokyo, Japan)
Published: May 24, 2023
Circulating extracellular vesicles are associated with pathophysiological condition including metabolic syndrome-related dysmetabolism in children and adolescents with obesity.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: March 20, 2023
The prognostic potential of fragmented CK18 serum levels in HCC patients reflecting disease progression and overall hepatocyte damage.
Journal: Frontiers in oncology
Published: July 14, 2022
Complement complex 1 subunit q-mediated hepatic stellate cell activation with connective tissue growth factor elevation is a prognostic factor for survival in rat and human chronic liver diseases.
Journal: Hepatology communications
Published: April 10, 2022
Last Updated: 09/26/2026